Moderna, Inc. (MRNA)

Health Care · Biological Products, (No Diagnostic Substances)

Moderna, Inc. (MRNA) is listed on Nasdaq, where its shares have traded since December 7, 2018. SentiSense covers Moderna, Inc. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances). Stéphane Bancel is its chief executive officer. The company reports 4,700 employees, and its corporate website is www.modernatx.com.

About Moderna, Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 765 institutions reported holding MRNA, with 317.6 million shares worth $22.2 billion in aggregate. The largest reported holders were FMR, Vanguard and BlackRock. Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter.

More on MRNA

  • MRNA sentiment: whether news and social coverage of Moderna, Inc. leans bullish or bearish, and the stories driving it.
  • MRNA ownership: all 765 reporting institutions, plus insider and congressional trades.
  • MRNA financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Moderna, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions

What does Moderna, Inc. do?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018.

What sector is MRNA in?

SentiSense classifies Moderna, Inc. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances).

Where does MRNA stock trade?

Moderna, Inc. (MRNA) is listed on Nasdaq, where its shares have traded since December 7, 2018.

Who is the CEO of Moderna, Inc.?

Stéphane Bancel is the chief executive officer of Moderna, Inc..